Cargando…
The DA VINCI study: is Ireland achieving ESC/EAS guideline–directed LDL-C goals?
BACKGROUND: The EU-wide, cross-sectional observational study of lipid-lowering therapy (LLT) use in secondary and primary care (DA VINCI) assessed the proportion of patients achieving low-density lipoprotein cholesterol (LDL-C) goals recommended by the European Society of Cardiology (ESC)/European A...
Autores principales: | Offiah, Gregory, O’Connor, Cormac, Kennedy, Cormac, Gallagher, Joe, O’Connor, Patricia, McAdam, Brendan, Ray, Kausik K., Schoonen, Marieke, Maher, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250484/ https://www.ncbi.nlm.nih.gov/pubmed/35776266 http://dx.doi.org/10.1007/s11845-022-03050-6 |
Ejemplares similares
-
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
por: Vallejo-Vaz, Antonio J., et al.
Publicado: (2022) -
Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study
por: Brandts, Julia, et al.
Publicado: (2023) -
Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved?: Results from the DA VINCI study
por: Siostrzonek, Peter, et al.
Publicado: (2021) -
Quantifying the impact of COVID-19 on chronic pain services in the Republic of Ireland
por: Mullins, Cormac Francis, et al.
Publicado: (2021) -
Abbreviated lipid guidelines for clinical practice: Based on ESC lipid guidelines 2019 and ESC cardiovascular disease prevention in clinical practice guidelines 2021
por: Maher, Vincent, et al.
Publicado: (2023)